Systemic Lupus Erythematosus (SLE) patients have an increased susceptibility to tuberculosis; such a case was reported in a 28-year old man. It is believed that Methotrexate used to reduce the activity of systemic lupus erythematosus and of rheumatoid arthritis had decreased the activity of his immune system and tends to develop tuberculosis.
